Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Heidelberg Pharma AG: A reportable insider transaction was published on 24th July 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 24th July 2025,
The Insider Transaction was made by Pahl, Prof. Dr. Andreas 
. The transaction toke place on 23rd July 2025. . The aggregated volume was 170.100,00 EUR, based on an average price of 1,89 EUR. The nature of the Investment was not specified.
Heidelberg Pharma AG: A reportable insider transaction was published on 24th July 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 24th July 2025,
The Insider Transaction was made by Pahl, Prof. Dr. Andreas . The transaction toke place on 23rd July 2025. . The aggregated volume was 170.100,00 EUR, based on an average price of 1,89 EUR. The nature of the Investment was not specified.
Heidelberg Pharma AG: A reportable insider transaction was published on 24th July 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 24th July 2025,
The Insider Transaction was made by Pahl, Prof. Dr. Andreas . The transaction toke place on 23rd July 2025. . The aggregated volume was 170.100,00 EUR, based on an average price of 1,89 EUR. The nature of the Investment was not specified.
Heidelberg Pharma AG: A reportable insider transaction was published on 24th July 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 24th July 2025,
The Insider Transaction was made by Pahl, Prof. Dr. Andreas . The transaction toke place on 23rd July 2025. . The aggregated volume was 170.100,00 EUR, based on an average price of 1,89 EUR. The nature of the Investment was not specified.
Dermapharm Holding SE: A reportable insider transaction was published on 4th June 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 4th June 2025,
The Insider Transaction was made by Feldmeier, Dr. Hans-Georg . The transaction toke place on 2nd June 2025. The order was executed at the trading place Deutsche Börse Frankfurt. . The aggregated volume was 99.735,15 EUR, based on an average price of 35,62 EUR. The nature of the Investment was Buy.
Deutsche Post AG: A reportable insider transaction was published on 8th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th May 2025,
The Insider Transaction was made by von Dosky, Jörg . The transaction toke place on 7th May 2025. The order was executed at the trading place CBOE EUROPE - DXE ORDER BOOKS (NL). . The aggregated volume was 6.482,41 EUR, based on an average price of 37,07 EUR. The nature of the Investment was not specified.
BASF SE: A reportable insider transaction was published on 7th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 7th May 2025,
The Insider Transaction was made by Asenkerschbaumer, Prof. Dr. Stefan . The transaction toke place on 5th May 2025. The order was executed at the trading place XETRA. . The aggregated volume was 74.981,41 EUR, based on an average price of 42,43 EUR. The nature of the Investment was Buy.
BASF SE: A reportable insider transaction was published on 7th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 7th May 2025,
The Insider Transaction was made by Carell, Prof. Dr. Thomas . The transaction toke place on 5th May 2025. The order was executed at the trading place XETRA. . The aggregated volume was 49.987,61 EUR, based on an average price of 42,43 EUR. The nature of the Investment was Buy.
Siemens Aktiengesellschaft: A reportable insider transaction was published on 7th May 2025. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 7th May 2025,
The Insider Transaction was made by Pausch, Hans . The transaction toke place on 2nd May 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 41.360,00 EUR, based on an average price of 206,80 EUR. The nature of the Investment was Sell.
Siemens Aktiengesellschaft: A reportable insider transaction was published on 19th April 2025. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 19th April 2025,
The Insider Transaction was made by Pausch, Hans . The transaction toke place on 8th April 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 36.276,00 EUR, based on an average price of 181,38 EUR. The nature of the Investment was Buy.
Nexus AG: A reportable insider transaction was published on 17th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 17th April 2025,
The Insider Transaction was made by König, Dr. Hans-Joachim . The transaction toke place on 14th April 2025. . The aggregated volume was 4.480.000,00 EUR, based on an average price of 70,00 EUR. The nature of the Investment was Sell.
Nexus AG: A reportable insider transaction was published on 17th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 17th April 2025,
The Insider Transaction was made by Rosenthal, Prof. Dr. Felicia . The transaction toke place on 14th April 2025. . The aggregated volume was 29.750,00 EUR, based on an average price of 70,00 EUR. The nature of the Investment was Sell.
Nynomic AG: A reportable insider transaction was published on 11th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 11th April 2025,
The Insider Transaction was made by Wörmcke, Hans . The transaction toke place on 9th April 2025. The order was executed at the trading place Frankfurt, XETRA. . The aggregated volume was 20.123,45 EUR, based on an average price of 11,82 EUR. The nature of the Investment was Buy.
Nynomic AG: A reportable insider transaction was published on 11th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 11th April 2025,
The Insider Transaction was made by Wörmcke, Hans . The transaction toke place on 8th April 2025. The order was executed at the trading place Frankfurt, XETRA. . The aggregated volume was 21.860,00 EUR, based on an average price of 12,14 EUR. The nature of the Investment was Buy.
Nynomic AG: A reportable insider transaction was published on 11th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 11th April 2025,
The Insider Transaction was made by Wörmcke, Hans . The transaction toke place on 10th April 2025. The order was executed at the trading place Frankfurt, XETRA. . The aggregated volume was 8.103,90 EUR, based on an average price of 11,90 EUR. The nature of the Investment was Buy.
Rubean AG: A reportable insider transaction was published on 9th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 9th April 2025,
The Insider Transaction was made by Mittnik, Prof. Dr. Stefan . The transaction toke place on 7th April 2025. The order was executed at the trading place Gettex. . The aggregated volume was 8.400,00 EUR, based on an average price of 4,20 EUR. The nature of the Investment was Buy.
CEWE Stiftung & Co. KGaA: A reportable insider transaction was published on 8th April 2025. The reporting obligation was triggered by a person related to Other executive.
Transaction reporting date: 8th April 2025,
The Insider Transaction was made by Waskönig, Jörg . The transaction toke place on 7th April 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 49.553,70 EUR, based on an average price of 94,39 EUR. The nature of the Investment was Buy.
Deutsche Post AG: A reportable insider transaction was published on 3rd April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 3rd April 2025,
The Insider Transaction was made by von Dosky, Jörg . The transaction toke place on 2nd April 2025. The order was executed at the trading place CBOE Europe - DXE Order Books (NL). . The aggregated volume was 22.963,24 EUR, based on an average price of 39,48 EUR. The nature of the Investment was not specified.
Deutsche Post AG: A reportable insider transaction was published on 2nd April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 2nd April 2025,
The Insider Transaction was made by von Dosky, Jörg . The transaction toke place on 1st April 2025. The order was executed at the trading place XETRA. . The aggregated volume was 38.786,57 EUR, based on an average price of 39,80 EUR. The nature of the Investment was Buy.
init innovation in traffic systems SE: A reportable insider transaction was published on 20th March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 20th March 2025,
The Insider Transaction was made by Munz, Jörg . The transaction toke place on 18th March 2025. . The aggregated volume was 158.340,00 EUR, based on an average price of 37,70 EUR. The nature of the Investment was not specified.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.